189 related articles for article (PubMed ID: 25045824)
1. Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: a randomized study.
Gaggar A; Coeshott C; Apelian D; Rodell T; Armstrong BR; Shen G; Subramanian GM; McHutchison JG
Vaccine; 2014 Sep; 32(39):4925-31. PubMed ID: 25045824
[TBL] [Abstract][Full Text] [Related]
2. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.
Krawczyk A; Ludwig C; Jochum C; Fiedler M; Heinemann FM; Shouval D; Roggendorf M; Roggendorf H; Lindemann M
Vaccine; 2014 Sep; 32(39):5077-82. PubMed ID: 24975813
[TBL] [Abstract][Full Text] [Related]
3. Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.
Milligan ID; Gibani MM; Sewell R; Clutterbuck EA; Campbell D; Plested E; Nuthall E; Voysey M; Silva-Reyes L; McElrath MJ; De Rosa SC; Frahm N; Cohen KW; Shukarev G; Orzabal N; van Duijnhoven W; Truyers C; Bachmayer N; Splinter D; Samy N; Pau MG; Schuitemaker H; Luhn K; Callendret B; Van Hoof J; Douoguih M; Ewer K; Angus B; Pollard AJ; Snape MD
JAMA; 2016 Apr; 315(15):1610-23. PubMed ID: 27092831
[TBL] [Abstract][Full Text] [Related]
4. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers.
Mancini-Bourgine M; Fontaine H; Scott-Algara D; Pol S; Bréchot C; Michel ML
Hepatology; 2004 Oct; 40(4):874-82. PubMed ID: 15382173
[TBL] [Abstract][Full Text] [Related]
5. Cellular and humoral immune response to a third generation hepatitis B vaccine.
Schumann A; Fiedler M; Dahmen U; Grosse-Wilde H; Roggendorf M; Lindemann M
J Viral Hepat; 2007 Aug; 14(8):592-8. PubMed ID: 17650294
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers.
Mancini-Bourgine M; Fontaine H; Bréchot C; Pol S; Michel ML
Vaccine; 2006 May; 24(21):4482-9. PubMed ID: 16310901
[TBL] [Abstract][Full Text] [Related]
7. Surface antibody and cytokine response to recombinant Chinese hamster ovary cell (CHO) hepatitis B vaccine.
Zhang W; Han L; Lin C; Wang H; Pang X; Li L; Gao P; Lin H; Gong X; Tang Y; Ma J; Zhang H; Wang C; Yang P; Li H; Sun M; He X
Vaccine; 2011 Aug; 29(37):6276-82. PubMed ID: 21722684
[TBL] [Abstract][Full Text] [Related]
8. Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens.
Couillin I; Pol S; Mancini M; Driss F; Bréchot C; Tiollais P; Michel ML
J Infect Dis; 1999 Jul; 180(1):15-26. PubMed ID: 10353856
[TBL] [Abstract][Full Text] [Related]
9. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
[TBL] [Abstract][Full Text] [Related]
10. [Specific T cell immune response in chronic hepatitis B patients treated with different doses of recombinant hepatitis B vaccine].
Xu QH; Zhang XH; Xie DY; Li JG; Chong YT; Yang L; Lu WL; Gao ZL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):334-6. PubMed ID: 18322594
[TBL] [Abstract][Full Text] [Related]
11. Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age.
Halperin SA; Ward B; Cooper C; Predy G; Diaz-Mitoma F; Dionne M; Embree J; McGeer A; Zickler P; Moltz KH; Martz R; Meyer I; McNeil S; Langley JM; Martins E; Heyward WL; Martin JT
Vaccine; 2012 Mar; 30(15):2556-63. PubMed ID: 22326642
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.
Knuf M; Habermehl P; Cimino C; Petersen G; Schmitt HJ
Vaccine; 2006 May; 24(22):4727-36. PubMed ID: 16616973
[TBL] [Abstract][Full Text] [Related]
13. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL
Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089
[TBL] [Abstract][Full Text] [Related]
14. Effect of GM-CSF in combination with hepatitis B vaccine on revacination of healthy adult non-responders.
Lin C; Zhu J; Zheng Y; Chen Y; Wu Z; Chong Y; Gao Z
J Infect; 2010 Apr; 60(4):264-70. PubMed ID: 20138189
[TBL] [Abstract][Full Text] [Related]
15. A pilot randomized controlled trial of dual-plasmid HBV DNA vaccine mediated by in vivo electroporation in chronic hepatitis B patients under lamivudine chemotherapy.
Yang FQ; Yu YY; Wang GQ; Chen J; Li JH; Li YQ; Rao GR; Mo GY; Luo XR; Chen GM
J Viral Hepat; 2012 Aug; 19(8):581-93. PubMed ID: 22762143
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India.
Velu V; Nandakumar S; Shanmugam S; Shankar EM; Thangavel S; Kulkarni PS; Thyagarajan SP
Pediatr Infect Dis J; 2007 Nov; 26(11):1038-41. PubMed ID: 17984812
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents.
Schiff GM; Sherwood JR; Zeldis JB; Krause DS
J Adolesc Health; 1995 Jan; 16(1):12-7. PubMed ID: 7742331
[TBL] [Abstract][Full Text] [Related]
18. Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B.
Lok AS; Pan CQ; Han SH; Trinh HN; Fessel WJ; Rodell T; Massetto B; Lin L; Gaggar A; Subramanian GM; McHutchison JG; Ferrari C; Lee H; Gordon SC; Gane EJ
J Hepatol; 2016 Sep; 65(3):509-16. PubMed ID: 27210427
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants.
Olivier C; Belohradsky BH; Stojanov S; Bonnet E; Petersen G; Liese JG
Vaccine; 2008 Jun; 26(25):3142-52. PubMed ID: 18502545
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of repeated high-dose hepatitis B vaccine (80 microg) in patients with chronic liver disease.
Aziz A; Aziz S; Li DS; Murphy L; Leone N; Kennedy M; Dhillon S; Van Thiel DH
J Viral Hepat; 2006 Apr; 13(4):217-21. PubMed ID: 16611186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
